Dual-Target MSLN/FAP CAR-NK Cells for Pleural and Peritoneal Mesothelioma

Clinical trial NCT07510815 · RECRUITING

Trial details

NCT number: NCT07510815
Sponsor: Beijing Biotech
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Malignant Pleural Mesotheliomas

Start date: 2026-03-02
Primary completion: 2027-03-14
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.